
    
      Double-blinded, placebo-controlled, 2-way crossover study in 30 menopausal women with
      untreated hot flushes treated with a neurokinin 3 receptor (NK3R) antagonist

      Aims:

      To investigate whether an NK3R antagonist can reduce menopausal flushing

      Treatment:

      4 weeks administration of active drug and placebo in random order
    
  